US final guidance on pre-clinical testing:
This article was originally published in Clinica
Executive Summary
The US FDA has published a final guidance on the pre-clinical testing recommended for resorbable adhesion barrier devices used in abdominal and or pelvic surgery. The June 18 guidance defends the use of adhesion reduction as a study endpoint.